VP and CFO of HiTech Pharmacal Co. Inc. (HITK, Financial) William J Peters sells 56,250 shares of HITK on 09/11/2009 at an average price of $21.86 a share.
Hi-Tech is a specialty pharmaceutical company developing manufacturing and marketing branded and generic products. The Company specializes in difficult to manufacture liquid and semi-solid dosage forms and produces a range of sterile ophthalmic otic and inhalation products. The Company's Health Care Products Division is a leading developer and marketer of branded prescription and OTC products for the diabetes marketplace. Hitech Pharmacal Co. Inc. has a market cap of $235.3 million; its shares were traded at around $20.75 with a P/E ratio of 16.1 and P/S ratio of 2.2.
Recent Trades of HiTech Pharmacal Co. Inc. by CEO:
Recent Trades of HiTech Pharmacal Co. Inc. by Directors and Officers:
Hi-Tech is a specialty pharmaceutical company developing manufacturing and marketing branded and generic products. The Company specializes in difficult to manufacture liquid and semi-solid dosage forms and produces a range of sterile ophthalmic otic and inhalation products. The Company's Health Care Products Division is a leading developer and marketer of branded prescription and OTC products for the diabetes marketplace. Hitech Pharmacal Co. Inc. has a market cap of $235.3 million; its shares were traded at around $20.75 with a P/E ratio of 16.1 and P/S ratio of 2.2.
Recent Trades of HiTech Pharmacal Co. Inc. by CEO:
- Sell: CEO, President, Sec'y, Treas., 10% Owner David S Seltzer sold 16,224 shares of HITK stock on 07/16/2009 at the average price of $12.66; the price of the stock has increased by 63.9% since.
Recent Trades of HiTech Pharmacal Co. Inc. by Directors and Officers:
- Sell: Officer Bryce M Harvey sold 2,000 shares of HITK stock on 07/16/2009 at the average price of $13.24; the price of the stock has increased by 56.72% since.
- Sell: Director, 10% Owner Reuben Seltzer sold 75,000 shares of HITK stock on 07/16/2009 at the average price of $12.8; the price of the stock has increased by 62.11% since.
- Sell: Director Yashar Hirshaut sold 10,000 shares of HITK stock on 07/16/2009 at the average price of $13; the price of the stock has increased by 59.62% since.
